Condition
Mesothelioma|Pancreatic Cancer|Ovarian Cancer|Non-small Cell Lung Cancer
Estimated Enrollment: 6
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Basic Science
Study ID Numbers: MORAb-009-006
Study First Received: January 7, 2011
Last Updated: September 28, 2016
Estimated Primary Completion Date: March 2013
Primary Outcome Measures:
Primary Objective: determine biodistribution of radiolabeled amatuximab in tumor and nontumor tissue|Secondary objectives: determine the safety of a single IV of Indium-CHX-A amatuximab|Pharmacokinetic and serum levels|uptake of Indium-CHX-A amatuximab|occurrence of HACA|correlate shed serum mesothelin to imaging
Sponsors and Collaborators:
Morphotek
Website Link: https://ClinicalTrials.gov/show/NCT01521325
